Voon, Hian Yan http://orcid.org/0000-0001-5269-7565
Pow, Jun Yan
Tan, Lee Na
Suharjono, Haris Njoo
Teo, Wan Sim
Article History
Received: 8 May 2018
Accepted: 24 June 2019
First Online: 11 July 2019
Ethics approval and consent to participate
: Ethical approval was granted by the Medical Research & Ethics Committee of Malaysia (NMRR ID 16–1016-31034). Informed consent was obtained from all patients during recruitment.
: Obtained from all patients and Director-General of Health, Malaysia.
: None of the authors have received any form of honoraria, funding, grant, employment or have financial interest in the manufacturer of Co-Amoxiclav™ (Amoxycillin + Clavulanic acid), Pharmaniaga (Shah Alam, Malaysia).